Patients with mutations in Parkin usually show juvenile PD (JPD, onset <21 years old) or early-onset PD (between 21 and 40 years old) with a slow clinical course, excellent response to low doses of levodopa, and frequent treatment-induced dyskinesias (Lohmann et al., 2009). The gene discussed is PRKN; the disease is Parkinson disease.